Subclavian Effort Thrombosis: Pathophysiology, Diagnosis, and Management

Abstract

Subclavian vein (SCV) effort thrombosis, also known as Paget-Schroetter syndrome or venous thoracic outlet syndrome, is an uncommon condition that affects individuals with an irregularly narrow thoracic outlet who engage in repetitive overhead motions of the affected arm. Venous injury arises from microtraumas that occur from the repetitive compression of the SCV between the first rib and the overlying clavicle. Additional sources of extrinsic compression can be due to the anterior scalene muscle, subclavius muscle, and costoclavicular ligament. SCV effort thrombosis is a distinct entity from other forms of deep venous thrombosis and requires unique diagnostic and treatment considerations. Early catheter-directed therapy in the form of pharmacomechanical or catheter-directed thrombolysis combined with prompt surgical thoracic outlet decompression offers patients the best chances for early and durable symptom relief.

Keywords

effort thrombosis - Paget-Schroetter - thoracic outlet syndrome - venous thrombosis - chest - thrombolysis - angioplasty - interventional radiology

Publication History

Article published online:
31 August 2022

• References

• 1 Hangge P, Rotellini-Coltvet L, Deipolyi AR, Albadawi H, Oklu R. Paget-Schroetter syndrome: treatment of venous thrombosis and outcomes. Cardiovasc Diagn Ther 2017; 7 (Suppl. 03) S285-S290
• 2 Karaolanis G, Antonopoulos CN, Koutsias SG. et al. A systematic review and meta-analysis for the management of Paget-Schroetter syndrome. J Vasc Surg Venous Lymphat Disord 2021; 9 (03) 801-810.e5
• 3 Thompson RW. Comprehensive management of subclavian vein effort thrombosis. Semin Intervent Radiol 2012; 29 (01) 44-51
• 4 Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med 2011; 364 (09) 861-869
• 5 Illig KA, Doyle AJ. A comprehensive review of Paget-Schroetter syndrome. J Vasc Surg 2010; 51 (06) 1538-1547
• 6 Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic outlet syndrome. J Vasc Surg 2007; 46 (03) 601-604
• 7 Kraaijpoel N, van Es N, Porreca E, Büller HR, Di Nisio M. The diagnostic management of upper extremity deep vein thrombosis: a review of the literature. Thromb Res 2017; 156: 54-59
• 8 Raptis CA, Sridhar S, Thompson RW, Fowler KJ, Bhalla S. Imaging of the patient with thoracic outlet syndrome. Radiographics 2016; 36 (04) 984-1000
• 9 Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 2004; 110 (05) 566-570
• 10 Cassada DC, Lipscomb AL, Stevens SL, Freeman MB, Grandas OH, Goldman MH. The importance of thrombophilia in the treatment of Paget-Schroetter syndrome. Ann Vasc Surg 2006; 20 (05) 596-601
• 11 Nakashima MO, Rogers HJ. Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants. Blood Res 2014; 49 (02) 85-94
• 12 Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med 2017; 377 (23) 2298
• 13 Sun L-M, Chung W-S, Lin C-L, Liang J-A, Kao C-H. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study. J Thromb Haemost 2016; 14 (03) 495-503
• 14 Cai TY, Rajendran S, Saha P, Dubenec S. Paget-Schroetter syndrome: a contemporary review of the controversies in management. Phlebology 2020; 35 (07) 461-471
• 15 Furfaro D, Stephens RS, Streiff MB, Brower R. Catheter-directed thrombolysis for intermediate-risk pulmonary embolism. Ann Am Thorac Soc 2018; 15 (02) 134-144
• 16 Urschel Jr HC, Patel AN. Paget-Schroetter syndrome therapy: failure of intravenous stents. Ann Thorac Surg 2003; 75 (06) 1693-1696 , discussion 1696
• 17 Lee JT, Karwowski JK, Harris EJ, Haukoos JS, Olcott IV C. Long-term thrombotic recurrence after nonoperative management of Paget-Schroetter syndrome. J Vasc Surg 2006; 43 (06) 1236-1243
• 18 Meier GH, Pollak JS, Rosenblatt M, Dickey KW, Gusberg RJ. Initial experience with venous stents in exertional axillary-subclavian vein thrombosis. J Vasc Surg 1996; 24 (06) 974-981 , discussion 981–983
• 19 Skeik N, Gits CC, Ehrenwald E, Cragg AH. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis. Vasc Endovascular Surg 2013; 47 (07) 519-523
• 20 Lee K, Istl A, Dubois L. et al. Fibrinogen level and bleeding risk during catheter-directed thrombolysis using tissue plasminogen activator. Vasc Endovascular Surg 2015; 49 (07) 175-179
• 21 Bækgaard N, Klitfod L, Jørgensen M. Should catheter-directed thrombolysis be monitored?. Phlebology 2016; 31 (1, Suppl): 5-10
• 22 Ouriel K, Kandarpa K, Schuerr DM, Hultquist M, Hodkinson G, Wallin B. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial. J Vasc Interv Radiol 1999; 10 (08) 1083-1091
• 23 Fleck D, Albadawi H, Shamoun F, Knuttinen G, Naidu S, Oklu R. Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations. Cardiovasc Diagn Ther 2017; 7 (Suppl. 03) S228-S237
• 24 Engelberger RP, Spirk D, Willenberg T. et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv 2015; 8 (01) e002027
• 25 Liang NL, Avgerinos ED, Marone LK, Singh MJ, Makaroun MS, Chaer RA. Comparative outcomes of ultrasound-assisted thrombolysis and standard catheter-directed thrombolysis in the treatment of acute pulmonary embolism. Vasc Endovascular Surg 2016; 50 (06) 405-410
• 26 Kaufman C, Kinney T, Quencer K. Practice trends of fibrinogen monitoring in thrombolysis. J Clin Med 2018; 7 (05) E111
• 27 Poorthuis MHF, Brand EC, Hazenberg CEVB. et al. Plasma fibrinogen level as a potential predictor of hemorrhagic complications after catheter-directed thrombolysis for peripheral arterial occlusions. J Vasc Surg 2017; 65 (05) 1519-1527.e26
• 28 Kohi MP, Kohlbrenner R, Kolli KP, Lehrman E, Taylor AG, Fidelman N. Catheter directed interventions for acute deep vein thrombosis. Cardiovasc Diagn Ther 2016; 6 (06) 599-611
• 29 Tang T, Chen L, Chen J, Mei T, Lu Y. Pharmacomechanical thrombectomy versus catheter-directed thrombolysis for iliofemoral deep vein thrombosis: a meta-analysis of clinical trials. Clin Appl Thromb Hemost 2019; 25: 1076029618821190
• 30 Lugo J, Tanious A, Armstrong P. et al. Acute Paget–Schroetter Syndrome: does the first rib routinely need to be removed after thrombolysis?. Ann Vasc Surg 2015; 29 (06) 1073-1077
• 31 Urschel HC, Razzuk MA. Paget-Schroetter syndrome: what is the best management?. Ann Thorac Surg 2000; 69 (06) 1663-1668
• 32 Kärkkäinen JM, Nuutinen H, Riekkinen T. et al. Pharmacomechanical thrombectomy in Paget-Schroetter syndrome. Cardiovasc Intervent Radiol 2016; 39 (09) 1272-1279
• 33 Kumar R, Harsh K, Saini S. et al. Treatment-related outcomes in Paget-Schroetter syndrome - a cross-sectional investigation. J Pediatr 2019; 207: 226-232.e1
• 34 de Kleijn RJCMF, Schropp L, Westerink J, de Borst GJ, Petri B-J. Timing of thoracic outlet decompression after thrombolysis for primary upper extremity deep venous thrombosis: a systematic review. Ann Vasc Surg 2020; 66: 654-661
• 35 Aboul Hosn M, Goffredo P, Man J. et al. Supraclavicular versus transaxillary first rib resection for thoracic outlet syndrome. J Laparoendosc Adv Surg Tech A 2020; 30 (07) 737-741
• 36 Rinehardt EK, Scarborough JE, Bennett KM. Current practice of thoracic outlet decompression surgery in the United States. J Vasc Surg 2017; 66 (03) 858-865
• 37 Stevens SM, Woller SC, Kreuziger LB. et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest 2021; 160 (06) e545-e608
• 38 Rajendran S, Cai TY, Loa J, Saha P, Dubenec S. Early outcomes using dedicated venous stents in the upper limb of patients with venous thoracic outlet syndrome: a single centre experience. CVIR Endovasc 2019; 2 (01) 22